StockNYSE · US · USDBasic Materials · Building Materials
$AMRZ
Amrize Ltd
Amrize is a building solutions company focused on North America, serving infrastructure, commercial and residential construction markets, as well as repair and refurbishment projects. It sells cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building solutions to customers including home builders, commercial builders, architects and designers, distributors, contractors and government authorities. Amrize operates across the United States, Canada, Colombia, Switzerland and Jamaica, with more than 19,000 employees and more than 1,000 sites, facilities and corporate offices. Amrize has two reportable segments. Building Materials supplies cement, natural and alternative aggregates, ready-mix concrete, asphalt and other construction materials. Building Envelope offers commercial and residential roofing and wall systems, including insulation, shingles, sheathing, waterproofing, coatings, adhesives, tapes and sealants. Its brands include Duro-Last, Elevate, Malarkey, OX Engineered Products, Enverge and Gaco. Amrize makes money through sales of these products and solutions. Its principal executive offices are in Zug, Switzerland, and it also has operational headquarters in Chicago.
Amrize (AMRZ) is investing $16M to expand its Memphis terminal, enhancing logistics for American-made cement. The project, set to finish in 2027, includes a 4000-ton silo and automated loading. It aims to support construction growth in the Tri-State Area, according to the company and local officials.
UBS kept Amrize rated Neutral and raised its price target to $46 from $42. The new target suggests 12.5% upside versus the Nov 13 close of $40.89. Recent analyst targets for Amrize range from $35.20 to $52.
Jefferies downgraded Amrize (NYSE:AMRZ) to Underperform, cutting its price target to $35.20 from $42.80. Analyst Glynis Johnson cited margin concerns due to rising costs and tough comparisons in 2027. The stock is down 23% year-to-date. Jefferies forecasts continued cost pressures will impact margins. Amrize reported Q3 2026 earnings beating profit estimates but missing revenue targets.
via TradingView
AMRZ sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning AMRZ (Amrize Ltd). Coverage has skewed bullish: 2 bullish, 0 neutral, and 1 bearish.
Recent AMRZ coverage spans financial news and earnings.
What's driving AMRZ
Capex expansion should improve regional cement supply reliability and logistics efficiency, supporting demand from builders in the Tri-State area.
The note is a valuation reset via a higher price target while keeping the same Neutral rating, which can support sentiment but is not a fundamental catalyst.
AlphAI scores every news story that mentions AMRZ with an AI model for sentiment and relevance, and aggregates insider trades from Amrize Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Amrize (AMRZ) is investing $16M to expand its Memphis terminal, enhancing logistics for American-made cement. The project, set to finish in 2027, includes a 4000-ton silo and automated loading. It aims to support construction growth in the Tri-State Area, according to the company and local officials.
UBS kept Amrize rated Neutral and raised its price target to $46 from $42. The new target suggests 12.5% upside versus the Nov 13 close of $40.89. Recent analyst targets for Amrize range from $35.20 to $52.
Jefferies downgraded Amrize (NYSE:AMRZ) to Underperform, cutting its price target to $35.20 from $42.80. Analyst Glynis Johnson cited margin concerns due to rising costs and tough comparisons in 2027. The stock is down 23% year-to-date. Jefferies forecasts continued cost pressures will impact margins. Amrize reported Q3 2026 earnings beating profit estimates but missing revenue targets.
Wall Street analysts downgraded five stocks: BETA Technologies (BETA), TransUnion (TRU), Molson Coors (TAP), Amrize (AMRZ), and another. Downgrades cited delivery delays, slower growth, soft demand, and cost pressures. BETA's Q3 revenue doubled, but deliveries were delayed. TransUnion's revenue rose 12.2%, but margins slipped. Molson Coors saw net sales fall 1.6% and lowered earnings guidance. Amrize adjusted EBITDA and revenue forecasts due to cost inflation.
Berenberg downgraded Amrize (NYSE:AMRZ) to Hold from Buy, lowering its price target to $46.00. The firm cited concerns over the roofing division's volume and margin pressures, reducing EPS forecasts for 2027-28. Amrize's Q3 2026 earnings beat estimates but revenue missed expectations, with management noting weather and inflation impacts.
Amrize, Canada's largest cement manufacturer, is expanding its 'Made in Canada' label to plants in British Columbia, Alberta, Ontario, and Nova Scotia, with a 'Manufactured in Québec' designation for its Quebec plant. The label guarantees Canadian manufacturing and quality, supporting local jobs. Amrize is also investing to expand production capacity to meet growing construction demand, backed by a $51 billion Canadian infrastructure fund.
Oppenheimer kept its Outperform rating on Amrize but reduced its price target to $52 from $55, citing a 5.5% decrease. The new target suggests a 25.7% upside from the Oct 30 close of $41.38. Recent analyst price targets for Amrize range from $39 to $48.
Amrize reported Q3 2026 revenues of $3.77B, up 2.2% YoY, with net income rising 3.3% to $558M. Pricing initiatives and acquisitions offset volume declines due to weather. Building Materials segment grew 1.8%, while Building Envelope faced challenges. Guidance updated to $12.2B-$12.4B in revenue and $2.95B-$3.05B in adjusted EBITDA for 2026.
DA Davidson kept its Neutral rating on Amrize but increased its price target to $43 from $40. The new target suggests a 3.3% upside from the Oct 29 close of $41.61. Recent analyst price targets for Amrize range from $32 to $48.
Wells Fargo kept Amrize at Equal-Weight but reduced its price target to $39 from $40, a 2.5% cut. This implies a 6.3% downside from the Oct 29 close of $41.61. Recent analyst price targets for Amrize range from $32 to $48.